Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

jefferies,-johnson-rice-maintain-buy-on-protagonist-therapeutics-(ptgx)-mar-2026

Jefferies, Johnson Rice Maintain Buy on Protagonist Therapeutics (PTGX) Mar 2026

Mar 18, 2026

Jefferies and Johnson Rice maintained Buy on Protagonist Therapeutics, Inc. (PTGX) on March 18, 2026. The PTGX analyst…

Read more
morgan-stanley-maintains-overweight-on-johnson-&-johnson-(jnj)-march-18,-2026

Morgan Stanley Maintains Overweight on Johnson & Johnson (JNJ) March 18, 2026

Mar 18, 2026

JNJ analyst rating: Morgan Stanley maintained an Overweight rating on Johnson & Johnson (JNJ) on March 18, 2026.…

Read more
nomura-downgrades-harrow-health,-inc.-(hrow)-to-neutral-march-18,-2026

Nomura Downgrades Harrow Health, Inc. (HROW) to Neutral March 18, 2026

Mar 18, 2026

Get analyst ratings, AI forecasts, and market updates in your inbox every morning. ~15% average open rate and…

Read more
evercore-isi-maintains-negative-on-pgr-the-progressive-corporation-march-18-2026

Evercore ISI Maintains Negative on PGR The Progressive Corporation March 18 2026

Mar 18, 2026

Evercore ISI maintained a Negative rating on The Progressive Corporation (PGR) on March 18, 2026, marking a hold…

Read more
a-look-at-fifth-third-bancorp-(fitb)-valuation-as-analyst-coverage-highlights-comerica-synergies-and-ai-cost-savings

A Look At Fifth Third Bancorp (FITB) Valuation As Analyst Coverage Highlights Comerica Synergies And AI Cost Savings

Mar 18, 2026

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…

Read more
ubs-maintains-buy-on-accenture-plc-(acn)-march-17,-2026

UBS Maintains Buy on Accenture plc (ACN) March 17, 2026

Mar 18, 2026

UBS maintained a Buy rating on Accenture plc (ACN) on March 17, 2026, reaffirming confidence in the company’s…

Read more
gold-co.-confirms-97%-gold-recovery-at-imwelo,-construction-on-track-for-2026-as-key-catalysts-approach

Gold Co. Confirms 97% Gold Recovery at Imwelo, Construction on Track for 2026 as Key Catalysts Approach

Mar 18, 2026

Lake Victoria Gold Ltd.’s (LVG:TSX; LVGLF:OTCQB; E1K:FSE) metallurgy testwork confirmed up to 97% gold recoveries at the fully…

Read more
morgan-stanley-maintains-overweight-on-celsius-holdings,-inc.-(celh)-march-2026

Morgan Stanley Maintains Overweight on Celsius Holdings, Inc. (CELH) March 2026

Mar 18, 2026

Morgan Stanley maintained its Overweight rating on Celsius Holdings, Inc. (CELH) on March 17, 2026, a signal that…

Read more
this-evommune-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-wednesday-–-apogee-therapeutics-(nasdaq:apge),-arcturus-therapeutics-(nasdaq:arct)

This Evommune Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday – Apogee Therapeutics (NASDAQ:APGE), Arcturus Therapeutics (NASDAQ:ARCT)

Mar 18, 2026

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
ubs-maintains-neutral-on-rh-(rh)-mar-17,-2026,-pt-cut-to-$160

UBS Maintains Neutral on Rh (RH) Mar 17, 2026, PT Cut to $160

Mar 18, 2026

On March 17, 2026 UBS maintained a Neutral RH analyst rating and cut the price target to $160.…

Read more
cowen-maintains-buy-on-tech-(bio-techne-corporation)-march-17,-2026

Cowen Maintains Buy on TECH (Bio-Techne Corporation) March 17, 2026

Mar 18, 2026

On March 17, 2026 Cowen & Co. maintained a Buy on Bio-Techne Corporation (TECH), a clear signal in…

Read more
cowen-maintains-hold-for-devon-energy-(dvn)-march-17,-2026

Cowen Maintains Hold for Devon Energy (DVN) March 17, 2026

Mar 18, 2026

Cowen & Co. maintained a Hold on Devon Energy Corporation (DVN) on March 17, 2026 and raised its…

Read more
  1. Pages:
  2. «
  3. 1
  4. 2
  5. 3
  6. 4
  7. 5
  8. 6
  9. 7
  10. ...
  11. 377
  12. »

Posts pagination

Newer posts Page 1 … Page 4 … Page 377 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.